{
    "clinical_study": {
        "@rank": "53626", 
        "acronym": "SETES", 
        "arm_group": {
            "arm_group_label": "cell therapy", 
            "arm_group_type": "Experimental", 
            "description": "study of the efficacy of skin equivalent comprising living cells and skin biodegradable substrate for the treatment of skin lesions"
        }, 
        "brief_summary": {
            "textblock": "In Russia the treatment nonhealing skin defects often limited to surgical interventions,\n      despite having developed modern methods of treatment of non-healing ulcers and other skin\n      imperfections. During the many years of research we have developed a skin equivalent\n      comprising living cells.\n\n      During pilot trial showed that the skin equivalent provides healing skin defect within 1-4\n      weeks in 95% of patients."
        }, 
        "brief_title": "The Study of the Effectiveness of Tissue Equivalent on the Basis of Cultured Cells to Heal Skin Blemishes", 
        "completion_date": {
            "#text": "July 2018", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Neurotrophic Ulcers", 
            "Burns"
        ], 
        "condition_browse": {
            "mesh_term": "Ulcer"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The presence of non-healing ulcer at least a month, an area of \u200b\u200bnot less than 3 cm2\n             or smaller area of deep defects;\n\n          -  Availability of burns II or III level;\n\n          -  Epidermolysis bullosa;\n\n          -  Availability of post-burn scars\n\n          -  Defects in the skin after surgery\n\n        Exclusion Criteria:\n\n          -  Acute and chronic diseases in the acute stage;\n\n          -  Autoimmune diseases of connective tissue (collagen);\n\n          -  Immunodeficiency states;\n\n          -  System of inflammatory diseases of the skin;\n\n          -  Conduct an aggressive corticosteroid therapy;\n\n          -  Acute coronary syndrome;\n\n          -  Acute disorders of cerebral circulation;\n\n          -  Availability of local inflammation in the acute stage;\n\n          -  Pregnancy;\n\n          -  Breast-feeding.\n\n          -  Positive results of the following tests: Anti-HIV-1 and -2, HIV-1Ag, anti-HTL VI\n             and-II, anti-HbcorAg, HBs-Ag, anti-HCV, anti-CMV, anti-Toxoplasma gondii, RW,\n             Neisseria gonorrheae, Chlamydia."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "1", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01884831", 
            "org_study_id": "USMA01082012"
        }, 
        "intervention": {
            "arm_group_label": "cell therapy", 
            "intervention_name": "study of the efficacy of skin equivalent comprising living cells and skin biodegradable substrate for the treatment of skin lesions", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "damage to the skin, the skin equivalent, cell therapy", 
        "lastchanged_date": "December 10, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ekaterinburg", 
                    "country": "Russian Federation", 
                    "zip": "620028"
                }, 
                "name": "Ural State Medical Academy"
            }, 
            "investigator": {
                "last_name": "Arteom V Korotkov, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Russian Federation"
        }, 
        "number_of_arms": "1", 
        "official_title": "Phase 2 The Use of Tissue-equivalent Based on Cultured Cells for Healing Skin Blemishes", 
        "overall_contact": {
            "email": "larim@mail.ru", 
            "last_name": "Arteom V Korotkov", 
            "phone": "+73432421546"
        }, 
        "overall_official": {
            "affiliation": "Ural State Medical Academy", 
            "last_name": "Oleg G Makeev, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Russia: Ministry of Health of the Russian Federation", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "efficiency", 
            "safety_issue": "Yes", 
            "time_frame": "six weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01884831"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ural State Medical Academy", 
            "investigator_full_name": "Korotkov Artem Vladimirovich", 
            "investigator_title": "Senior Research Fellow", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Ural State Medical Academy", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ural State Medical Academy", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}